Sterilization Services Companies

The sterilization services market is projected to reach USD 5.49 billion by 2030 from USD 3.75 billion in 2025, at a CAGR of 7.9% during the forecast period.

The market for sterilization services is growing due to the rising prevalence of hospital-acquired infections (HAIs), increasing surgical procedure volumes, heightened focus on food sterilization to combat foodborne illnesses, and the growing trend of outsourcing sterilization to specialized contract service providers. Additionally, stricter regulatory requirements for sterile packaging in the pharmaceutical and medical device sectors are further fueling market demand.

In January 2025, Medistri launched a new facility in Székesfehérvár, Hungary, with a sterilization capacity of up to 15,000 pallets/year and a chamber accommodating 16 pallets at a time. This USD 4.3 Mn (CHF 3.5 million) investment includes in-house laboratory services and is ISO 13485 audited—designed to enhance logistical reach and client proximity in Central Europe.

In September 2024, BGS expanded into the US market, establishing a 100,000 sq ft state-of-the-art electron beam sterilization facility in Imperial, Pennsylvania, near Pittsburgh International Airport. This venture is expected to be operational by mid-2025 as BGS US LLC, bring fully automated electron beam irradiation capabilities to the US, targeting the high-growth sterilization market for medical devices.

To know about the assumptions considered for the study download the pdf brochure

The sterilization services market is competitive, featuring companies such as STERIS (Ireland), Sotera Health (US), Servizi Italia S.p.A (Italy), E-BEAM Services, Inc. (US), BGS Beta-Gamma-Service GmbH & Co. KG (Germany), Medistri SA (Switzerland), H.W. Andersen Products Ltd. (UK), Cretex Companies (US), Life Science Outsourcing, Inc. (US), Microtrol Sterilisation Services Pvt. Ltd. (India), Cosmed Group (US), Centerpiece (US), Avantti Medi Clear (Mexico), Steripure (France), Europlaz (UK), Midwest Sterilization Corporation (US), Blue Line Sterilization Services, LLC (US), SteriPack Group (Ireland), SteriTek, Inc. (US), Sterilization Services (US), NextBeam (US), Meridian Medical (UK), Prince Sterilization Services, LLC (US), C.G. Laboratories, LLC (US), Pro-tech Design and Manufacturing Inc. (US), ClorDiSys Solutions Inc. (US), and Nutekk Bravo, LLC (US). These market players have implemented several strategies, including acquisitions, agreements, collaborations, and expansions, to enhance their positions in the market.

STERIS secures the top position in the global sterilization services market owing to its comprehensive service portfolio, including steam, low-temperature, gamma, EtO, and electron beam sterilization, backed by strong sterility assurance solutions. Its consistent revenue growth (2022–2024) and leadership in Applied Sterilization Technologies reinforce its global market dominance. Strategic acquisitions, such as BD’s surgical and sterilization assets in 2023, and sustained R&D investments (USD 98–107 million annually) highlight its commitment to innovation and expansion. With an established brand reputation in North America and a growing international footprint, STERIS has built resilience through diversification of customers and services. Despite competitive pressures and regional dependency, its scale, technological breadth, and financial strength position it as the clear leader in driving innovation and long-term growth in the sterilization services market.

Sotera Health secures the second position in the global sterilization services market due to its strong brand presence and diversified portfolio spanning medical device, pharmaceutical, and food industry sterilization needs. In 2024, the company generated USD 1.10 billion in revenues, marking steady growth supported by expansions in the US and Europe. Through its subsidiary Sterigenics S.A.S., Sotera strategically invested in electron beam (E-beam) technology, enhancing its capabilities and safety standards for medical and pharmaceutical products. Its emphasis on portfolio strengthening and operational expansion has enabled it to consolidate market share and build long-term client trust. However, reliance on North America and Europe makes geographic concentration a competitive vulnerability, pushing the company to prioritize emerging markets such as Brazil, Mexico, India, and Russia for future growth. Overall, Sotera’s scale, technology-driven expansion, and consistent investment in capabilities justify its ranking as the second-largest player globally.

Servizi Italia S.p.A. ranks third in the global sterilization services market, supported by its strong presence in Italy, Brazil, and Turkey. In 2024, the company reported USD 314.2 million in net revenues, with steady growth driven by inflation adjustments and heightened demand in Italy. Its surgical instrument sterilization segment accounted for 18.6% of total revenues, underscoring the company’s strong specialization. Strategic moves such as the 2024 merger with Ekolav S.r.l. and earlier investments in Steritek demonstrate Servizi’s focus on cost optimization and portfolio diversification into validation and higher-margin services. However, competitive intensity in Italy and Brazil, coupled with limited global expansion, continues to constrain growth relative to larger multinational peers. Despite these challenges, its disciplined expansion strategy and solid foothold in key regional markets justify its position as the third-largest sterilization services provider.

Market Ranking

The European sterilization services market is primarily led by STERIS (Ireland), Sotera Health (US), and Servizi Italia S.p.A (Italy), each distinguished by its leadership in sterilization, hygiene, and barrier solutions. These companies command the largest share of the sterilization services market due to their comprehensive portfolios, ongoing innovation, robust global footprint, and strategic expansion efforts. STERIS plc (US/Ireland) asserts its market-leading position in Europe through a comprehensive sterilization services portfolio, including EtO, e-beam, gamma, X-ray, vaporized hydrogen peroxide, and sterilization validation services.

Sotera Health (US) has a leading share in the sterilization services market through its two business segments: Sterigenics and Nordion. With the combination of Sterigenics, the terminal sterilization business, and Nordion, the Co-60 supply business, it provides sterilization modality selection and sterilization validation services for a variety of sterilization modalities, including the three major modalities offered by Sterigenics—gamma irradiation, EO processing, and E-beam.

Servizi Italia (Italy) plays an instrumental role in sterilization services through its Steril C division. Servizi Italia excels in providing specialized surgical instrument sterilization services. These offerings encompass the detailed planning and execution of washing, packaging, and sterilization for owned and rented surgical instruments and accessories used in operating theatres. The company has a geographic presence across Italy, Brazil, Turkey, India, Albania, and Morocco.

Related Reports:

Sterilization Services Market by Method (Electron Beam, EtO, Steam, Gamma, X-Ray, Hydrogen Peroxide), Type (Contract Sterilization, Validation Services), Mode of Delivery (Off-Site, On-Site), End User & Region - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com